Ruiyuan Biotech

睿源生物

Ruiyuan Biotech

Biotech/Healthcare

Ruiyuan Bio focuses on key scientific questions surrounding mesenchymal stem cells, such as their 'unclear in vivo fate and unknown mechanism of action.' The company seeks to break through the technical bottleneck of translating stem cells from clinical medical technology into drugs through…

Latest round: Series A Extension (2025)

Source: ChinaBulls — chinabulls.com

Last updated 2025-02-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.